Clinical trial · Interventional
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study
Real-Time Monitoring of Chemotherapy Side Effects in Patients With Gastro-Intestinal Malignancies
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This trial tests new methods and materials for the real-time chemotherapy-associated side effects monitoring support system (RT-CAMSS) in patients with gastrointestinal cancers undergoing chemotherapy. RT-CAMSS is a monitoring support system that provides patients with evidence-based information and side-effect management and coping skills, emotional support and validation, and proactive care via text messages and questionnaires as they undergo chemotherapy.
Conditions
Conditions (86)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage 0 Gastric Cancer AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage I Esophageal Adenocarcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage I Gastric Cancer AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage IIA Gastric Cancer AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage IIB Gastric Cancer AJCC v8 | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Consultation | Other | — | UNRESOLVED |
| Patient Monitoring System | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Health Services Research (RT-CAMSS)
- description
- Patients receive RT-CAMSS over 2 months or until chemotherapy is discontinued, whichever is earlier. RT-CAMSS consists of text messages addressing knowledge about specific cancer type and chemotherapy, side-effect prevention, suggestions of lifestyle behavioral changes and emotional support, and preparation for surgery. Patients then record their symptoms through answering a series of questionnaires and receive tailored feedback according to their answers, including a consultation with a nurse.
- interventionNames
- Other: Patient Monitoring System
- Other: Questionnaire Administration
- Other: Consultation
Primary outcomes (9)
- measure
- Feasibility and Engagement
- timeFrame
- Up to 2 months or until chemotherapy is discontinued, whichever is earlier
- description
- Will be measured through study accrual, attrition, and system usage frequencies. We aim for accrual at a rate of 50% to match our prior study but a rate over 30% will be feasible. The intervention will be considered feasible if attrition does not exceed 30%. 90% of participants reporting their symptoms at least once will be considered adequate.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with gastric, esophageal, pancreatic or colorectal cancer * Scheduled to start intravenous (IV) chemotherapy or has started IV chemotherapy * Able to read and understand English * Able to provide signed and dated informed consent form * Have a mobile device with text message capability * Know or willing to learn how to use text messaging Exclusion Criteria: * \< 18 years of age * Cognitive impairment documented in the electronic medical record (EMR), biological variables (sex)
References
Publications (0)
Data not yet available